Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7bffc4ee897658b32ddedf04b38cad98 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-7051 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-70539 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-74 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-725 |
filingDate |
2002-09-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0c2345d65375fb2ff626f48d85cb5f18 |
publicationDate |
2003-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CA-2486545-A1 |
titleOfInvention |
Peptides capable of modulating immune response |
abstract |
Provided are peptides capable of inhibiting proliferation of peripheral blood mononuclear cells (PBMCs) derived from HLA class II alpha 2 chain. Furthermore, peptides capable of inhibiting proliferation of peripheral blood mononuclear cells (PBMCs) derived from T-cell immune response cDNA 7 (TIRC7) costimulatory molecule are described. Compositions comprising such peptides and their use for the treatment of immune diseases are provided. |
priorityDate |
2001-09-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |